MLM
MRNA icon

Mount Lucas Management’s Moderna MRNA Stock Holding History

Mount Lucas Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,693
Closed -$318K – 120
2022
Q3 		$318K Sell
2,693
-53
-2% -$8.04K 0.11% 86
2022
Q2 		$392K Buy
2,746
+265
+11% +$37.9K 0.13% 78
2022
Q1 		$427K Buy
2,481
+152
+7% +$25.6K 0.12% 97
2021
Q4 		$592K Buy
+2,329
New +$681K 0.17% 95

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mount Lucas Management's MRNA Position: Q4 2022 in Review

Mount Lucas Management sold out of Moderna (MRNA) in Q4 2022, closing a stake of 2,693 shares — an estimated $318K sold.

Mount Lucas Management first reported a position in MRNA in Q4 2021 and held it in 4 quarters. The position peaked at $592K in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Mount Lucas Management reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Mount Lucas Management sold 2,693 Moderna shares in Q4 2022, an estimated $318K.
  • Mount Lucas Management first reported a position in Moderna in Q4 2021 and held it in 4 quarters.
  • Mount Lucas Management's Moderna position peaked at $592K in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Mount Lucas Management's 13F filing for Q4 2022, filed 14 Feb 2023.